Skip to main content
. 2022 Oct 21;25(Suppl 6):e26009. doi: 10.1002/jia2.26009
Abstract P162 – Table 1. Change from baseline by naive status.
Experienced Experienced Experienced Naive Naive Naive pa
T0 mean SD or median (IQR) or N (%) T1 mean SD or median (IQR) or N (%) T1‐T0 mean (95% CI) T0 mean SD or median (IQR) or N (%) T1 mean SD or median (IQR) or N (%) T1‐T0 mean (95% CI)
Weight, kg 75.6±15.2 76.0±13.8 0.3 (‐0.2 to 0.8) 69.9±12.5 71.9±12.3 1.4 (0.4 to 2.2)b 0.04
Total cholesterol, mg/dL 194±42 188±40 ‐5.4 (‐8.6 to ‐2.2)b 171±46 183±38 15.0 (7.3 to 22.6)b <0.0001
LDL‐c, mg/dL 111±38 108±35 ‐2.5 (‐5.5 to 0.4) 99±38 108±31 9.8 (3.4 to 16.2)b 0.001
HDL‐c, mg/dL 54±19 55±18 0.1 (‐1.0 to 1.3) 48±19 52±17 4.8 (1.9 to 7.8)b 0.002
TGL, mg/dL 115 (85 to 170) 104 (76 to 153) ‐13.1 (‐20.4 to ‐5.8)b 97.5 (77 to 149) 99 (77 to 131) 0 (‐13.5 to 13.5) 0.09
BG in nondiabetic 93±17 96±21 2.2 (0.5 to 4.0)b 89±13 89±12 0.4 (‐2.6 to 0.4) 0.29
BG in diabetic 165±72 168±70 2.3 (‐30.2 to 34.9) 170±26 173±72 32 (‐108 to 171) 0.53
eGFR mL/min 86.3±21.9 83.5±20.5 ‐2.5 (‐2.9 to ‐1.1)b 105.1±29.4 89.9±23.7 ‐15.3 (‐19.9 to ‐10.8)b <0.0001
AST IU/L 22 (18 to 27) 23 (18 to 28) ‐0.6 (‐3.4 to 2.1) 25 (19 to 31) 22 (19 to 27) ‐3.8 (‐7.8 to 0.3) 0.22
ALT IU/L 22 (16 to 31) 23 (16 to 34) 2.4 (0.8 to 4.0)b 23 (17 to 31) 19 (14 to 26) ‐5.8 (‐11.0 to ‐0.7)b 0.0002
acNASH (N = 311) (n = 272) ‐0.22 (‐0.70 to 0.25) (N = 77) (N = 70) ‐0.95 (‐1.55 to ‐0.35)b 0.059
<4.15 272 (87.5%) 242 (89.0%) —————————— 52 (67.5%) 62 (88.6%) ———————————— ————————————‐
4.15 to 7.73 33 (10.6%) 23 (8.5%) ——————————— 21 (27.3%) 7 (10.0%) ——————————‐ ————————————‐
≥7.74 6 (1.9%) 7 (2.6%) ——————————– 4 (5.2%) 1 (1.4%) ——————————– ————————————–

acNASH, AST/creatinine Non Alcoholic Steato‐Hepatitis score; ALT, alanine aminotransferase; AST, aspartate aminotransferase; BG, basal glucose; eGFR, estimated glomerular filtration rate; HDL‐c, high density lipoprotein‐cholesterol; IQR, interquartile range; IU, international unit; LDL‐c, low density lipoprotein‐cholesterol; SD, standard deviation; TGL, triglycerides.

aT1‐T0 comparison by naïve status;

bp < 0.05 for change from baseline.